Bumrungrad Hospital Pcl Stock Shares Outstanding
BUGDFDelisted Stock | USD 6.40 0.00 0.00% |
Bumrungrad Hospital PCL fundamentals help investors to digest information that contributes to Bumrungrad Hospital's financial success or failures. It also enables traders to predict the movement of Bumrungrad Pink Sheet. The fundamental analysis module provides a way to measure Bumrungrad Hospital's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bumrungrad Hospital pink sheet.
Bumrungrad |
Bumrungrad Hospital PCL Company Shares Outstanding Analysis
Bumrungrad Hospital's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Bumrungrad Hospital Shares Outstanding | 794.89 M |
Most of Bumrungrad Hospital's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bumrungrad Hospital PCL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Bumrungrad Hospital PCL has 794.89 M of shares currently outstending. This is 340.3% higher than that of the sector and significantly higher than that of the Shares Outstanding industry. The shares outstanding for all United States stocks is 39.01% lower than that of the firm.
Bumrungrad Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bumrungrad Hospital's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bumrungrad Hospital could also be used in its relative valuation, which is a method of valuing Bumrungrad Hospital by comparing valuation metrics of similar companies.Bumrungrad Hospital is currently under evaluation in shares outstanding category among its peers.
Bumrungrad Fundamentals
Return On Equity | 0.23 | |||
Return On Asset | 0.14 | |||
Profit Margin | 0.21 % | |||
Operating Margin | 0.26 % | |||
Current Valuation | 4.63 B | |||
Shares Outstanding | 794.89 M | |||
Shares Owned By Insiders | 2.34 % | |||
Shares Owned By Institutions | 5.92 % | |||
Price To Earning | 303.00 X | |||
Price To Book | 9.22 X | |||
Price To Sales | 0.26 X | |||
Revenue | 12.46 B | |||
Gross Profit | 4.87 B | |||
EBITDA | 2.76 B | |||
Net Income | 1.22 B | |||
Cash And Equivalents | 6.33 B | |||
Cash Per Share | 7.96 X | |||
Total Debt | 23.22 M | |||
Debt To Equity | 0 % | |||
Current Ratio | 3.10 X | |||
Book Value Per Share | 22.74 X | |||
Cash Flow From Operations | 3.56 B | |||
Earnings Per Share | 0.14 X | |||
Number Of Employees | 40 | |||
Beta | 0.38 | |||
Market Capitalization | 5.14 B | |||
Total Asset | 20.86 B | |||
Annual Yield | 0.01 % | |||
Net Asset | 20.86 B | |||
Last Dividend Paid | 3.2 |
About Bumrungrad Hospital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bumrungrad Hospital PCL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bumrungrad Hospital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bumrungrad Hospital PCL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Bumrungrad Pink Sheet
If you are still planning to invest in Bumrungrad Hospital PCL check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bumrungrad Hospital's history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
CEOs Directory Screen CEOs from public companies around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |